BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38568467)

  • 1. Prandial Insulins: A Person-Centered Choice.
    Attri B; Nagendra L; Dutta D; Shetty S; Shaikh S; Kalra S; Bhattacharya S
    Curr Diab Rep; 2024 Jun; 24(6):131-145. PubMed ID: 38568467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-hundred year evolution of prandial insulin preparations: From animal pancreas extracts to rapid-acting analogs.
    Bolli GB; Porcellati F; Lucidi P; Fanelli CG; Owens DR
    Metabolism; 2022 Jan; 126():154935. PubMed ID: 34762931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications.
    Owens DR; Bolli GB
    Diabetes Obes Metab; 2020 May; 22(5):743-754. PubMed ID: 31930670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007 Jun; 29(6 Pt 1):1254-70. PubMed ID: 18036388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin.
    Heinemann L; Baughman R; Boss A; Hompesch M
    J Diabetes Sci Technol; 2017 Jan; 11(1):148-156. PubMed ID: 27378794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the value of faster acting prandial insulin? Focus on ultra rapid lispro.
    Heise T; Piras de Oliveira C; Juneja R; Ribeiro A; Chigutsa F; Blevins T
    Diabetes Obes Metab; 2022 Sep; 24(9):1689-1701. PubMed ID: 35593434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing hyperglycemia from hospital admission to discharge.
    Moghissi ES
    Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of biphasic insulin aspart in patients with type 2 diabetes.
    Halimi S; Raskin P; Liebl A; Kawamori R; Fulcher G; Yan G
    Clin Ther; 2005; 27 Suppl B():S57-74. PubMed ID: 16519038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid-acting insulin analogues in Basal-bolus regimens in type 1 diabetes mellitus.
    Garg S; Ampudia-Blasco FJ; Pfohl M
    Endocr Pract; 2010; 16(3):486-505. PubMed ID: 20150026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes.
    Yacoub T
    Postgrad Med; 2017 Nov; 129(8):791-800. PubMed ID: 29032696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.
    Akturk HK; Snell-Bergeon JK; Rewers A; Klaff LJ; Bode BW; Peters AL; Bailey TS; Garg SK
    Diabetes Technol Ther; 2018 Oct; 20(10):639-647. PubMed ID: 30207748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin lispro, a new insulin analog.
    Kucera ML; Graham JP
    Pharmacotherapy; 1998; 18(3):526-38. PubMed ID: 9620104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosimilars and Novel Insulins.
    Ampudia-Blasco FJ
    Am J Ther; 2020; 27(1):e52-e61. PubMed ID: 31764128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ultrafast-acting insulin analogues in the management of diabetes.
    Kruger DF; Novak LM
    J Am Assoc Nurse Pract; 2019 Sep; 31(9):537-548. PubMed ID: 31385938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthetic Human Insulin and Insulin Analogs.
    Rodbard HW; Rodbard D
    Am J Ther; 2020; 27(1):e42-e51. PubMed ID: 31876563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effect of insulin glulisine to insulin aspart on breakfast postprandial blood glucose levels in children with type 1 diabetes mellitus on multiple daily injections.
    Cemeroglu AP; Kleis L; Wood A; Parkes C; Wood MA; Davis AT
    Endocr Pract; 2013; 19(4):614-9. PubMed ID: 23425652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review.
    Fordan S; Raskin P
    Vasc Health Risk Manag; 2009; 5(1):225-31. PubMed ID: 19436644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus.
    Kinsley B
    Clin Ther; 2007; 29 Suppl D():S153-60. PubMed ID: 18191067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.